Daktarin Aktiv Spray Powder
- Do you have athlete’s foot? Daktarin Aktiv Spray treats sweat rash and athletes foot, cased by fungal infection.
- The first active ingredient helps to destroy the bacteria that causes fungal infection.
- secondly a mild steroid reduces inflammation, redness and itching.
£5.99 – £8.49
What is Daktarin Aktiv Spray Powder used for?
Do you have athlete’s foot? Daktarin Aktiv Spray Powder treats sweat rash and athletes foot, casued by fungal infection.The active ingredient helps to destroy the bacteria that causes fungal infection. secondly a mild steroid reduces inflammation, redness and itching.
What is athletes foot?
Athletes foot is a contagious fungal infection. The foot is the main area affected. However,it can also affect the hands. Additionally, the infection can spread to the toenails. Athletes foot is not serious but in can be difficult to cure. Use Daktarin spray regularly to prevent re-infection.
The causes of athletes foot.
Tinea fungus is the cause of athletes foot.Direct contact with an infected person will pass on the condition. Also, contaminated surfaces can spread the fungus.
How to use.
Wash the affected area and dry it well.
Shake the can thoroughly.
Hold the can 3 inches from your skin and spray the affected area.
Use twice a day until your affected areas of skin look normal.
Regular use helps to protect from reinfection.
See our foot care range
See our pain relief range
1 Pack, 2 Pack, 3 Pack
Adverse drug reactions from spontaneous reports during the worldwide postmarketing experience with Daktarin that meet threshold criteria are included. The adverse drug reactions are ranked by frequency, using the following convention:
Very common ≥ 1/10
Common ≥ 1/100 and < 1/10 Uncommon ≥ 1/1,000 and <1/100 Rare ≥ 1/10,000, < 1/1,000 Very rare < 1/10,000, including isolated reports The frequencies provided below reflect reporting rates for adverse drug reactions from spontaneous reports, and do not represent more precise estimates of incidence that might be obtained in clinical or epidemiological studies. Immune system disorders Very rare: anaphylactic reaction, hypersensitivity, Skin and subcutaneous tissue disorders Very rare: Angioedema, urticaria, contact dermatitis, rash, erythema, pruritus, skin burning sensation General disorders and administration site conditions Rare: application site reactions, including application site irritation Reporting of suspected adverse reactions
Click here for the Patient leaflet